EUVIMEDEUVIMED entdecken
Crossref

Dynamics of Serum Inflammatory Markers Predict Survival After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer

Young Sub Lee iD, Chan Joo Kim, Jin-Hwi Kim, Yong Seok Lee, Songmi Jeong, Sea-Won Lee, Kwangil Yim

Asia-Pacific Journal of Clinical Oncology · 2026

DOI: 10.1111/ajco.14201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, 2026. Verfasst von Young Sub Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pathology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Chemoradiotherapy, Biomarkers, Tumor, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: The Catholic Medical Center Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Cervical cancer is caused by persistent infection with the human papillomavirus. This study aimed to investigate whether the changes in serum inflammatory markers between baseline and posttreatment can predict survival in cervical cancer undergoing definitive chemoradiotherapy (CCRT).

Methods

Eighty‐one Stage IB–IVA cervical cancer patients treated with definitive CCRT, with serum inflammatory markers obtained at diagnosis and after completion of pre‐planned therapy, were included. The percent changes of post‐/pretreatment levels × 100% were calculated for neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), monocyte‐to‐lymphocyte ratio (MLR), systemic inflammation response index (SIRI), and systemic immune‐inflammation index (SII). The cutoffs were obtained with the maximal chi‐square statistics.

Results

At a median follow‐up of 28 months, the 2‐year overall survival (OS) was 75.4%. The 2‐year OS for patients with low versus high percent change was as follows: post‐/pre‐NLR (87.7% vs. 67.8%), post‐/pre‐MLR (75.9% vs. 71.1%), post‐/pre‐SIRI (76.5% vs. 61.7%), and post‐/pre‐SII (91.7% vs. 67.2%) (all p < 0.05). The hazard ratios (HR) in multivariate analysis were as follows: post‐/pre‐NLR (5.53, 95% confidence interval [CI]: 1.65–18.52), post‐/pre‐MLR (3.39, 95% CI: 1.39–8.26), post‐/pre‐SIRI (5.11, 95% CI: 1.92–13.57), and post‐/pre‐SII (6.57, 95% CI: 1.77–24.36) (all p < 0.05).

Conclusion

This study demonstrates the impact of the dynamics of serum inflammatory markers on survival. It has been consistently demonstrated across the markers. To adopt these markers for personalized treatment decisions, a better understanding of their relation with the actual tumor microenvironment is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsChemoradiotherapyBiomarkers, TumorInflammationHumansFemaleMiddle AgedAdultAgedPrognosisRetrospective Studies

Stichwörter der Autor:innen

cervical cancerchemoradiotherapyneutrophil‐to‐lymphocyte ratioserum inflammatory markerswhite blood cells

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Hospital Pathology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Obstetrics and Gynecology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Obstetrics and Gynecology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Hospital Pathology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

ORCID-Profile: Young Sub Lee

Förderung

  • The Catholic Medical Center Research Foundation

Zitieren

APA

Lee, Y. S., Kim, C. J., Kim, J. H., Lee, Y. S., Jeong, S., Lee, S. W., & Yim, K. (2026). Dynamics of Serum Inflammatory Markers Predict Survival After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.14201

Vancouver

Lee YS, Kim CJ, Kim JH, Lee YS, Jeong S, Lee SW, et al. Dynamics of Serum Inflammatory Markers Predict Survival After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer. Asia-Pacific Journal of Clinical Oncology. 2026. doi:10.1111/ajco.14201

BibTeX
@article{Lee2026,
  author = {Lee, Young Sub and Kim, Chan Joo and Kim, Jin-Hwi and Lee, Yong Seok and Jeong, Songmi and Lee, Sea-Won and Yim, Kwangil},
  title = {Dynamics of Serum Inflammatory Markers Predict Survival After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1111/ajco.14201}
}
Kostenlos starten →